Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Total Debt (2016 - 2025)

Historic Total Debt for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $1.2 billion.

  • Haemonetics' Total Debt fell 0.85% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year decrease of 0.85%. This contributed to the annual value of $1.2 billion for FY2025, which is 5162.15% up from last year.
  • As of Q4 2025, Haemonetics' Total Debt stood at $1.2 billion, which was down 0.85% from $1.2 billion recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Total Debt peaked at $1.2 billion during Q3 2024, and registered a low of $707.6 million during Q2 2021.
  • Over the past 5 years, Haemonetics' median Total Debt value was $796.1 million (recorded in 2021), while the average stood at $936.1 million.
  • As far as peak fluctuations go, Haemonetics' Total Debt surged by 15088.52% in 2022, and later crashed by 678.91% in 2023.
  • Over the past 5 years, Haemonetics' Total Debt (Quarter) stood at $780.8 million in 2021, then decreased by 1.79% to $766.8 million in 2022, then rose by 13.54% to $870.6 million in 2023, then surged by 40.69% to $1.2 billion in 2024, then dropped by 0.01% to $1.2 billion in 2025.
  • Its Total Debt was $1.2 billion in Q4 2025, compared to $1.2 billion in Q3 2025 and $1.2 billion in Q2 2025.